Yoshihiko Hatanaka
Director/Board Member chez SONY GROUP CORPORATION
Profil
Actuellement, Yoshihiko Hatanaka est président d'Astellas Pharma, Inc. Il est également membre du conseil d'administration de Sony Corp. Au cours de sa carrière passée, il a occupé le poste de président et directeur général d'Astellas Pharma US, Inc, de président et directeur général d'Astellas US LLC et de directeur de la planification d'entreprise de Fujisawa Pharmaceutical Co. Il a obtenu un diplôme de premier cycle à l'université d'Hitotsubashi.
Postes actifs de Yoshihiko Hatanaka
| Sociétés | Poste | Début |
|---|---|---|
| SONY GROUP CORPORATION | Director/Board Member | 18/06/2019 |
| SHISEIDO COMPANY, LIMITED | Director/Board Member | - |
Anciens postes connus de Yoshihiko Hatanaka
| Sociétés | Poste | Fin |
|---|---|---|
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Chairman | 01/03/2009 |
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Chief Executive Officer | - |
Fujisawa Pharmaceutical Co., Ltd.
 Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | - |
| ASTELLAS PHARMA INC. | Chief Executive Officer | 01/04/2018 |
Formation de Yoshihiko Hatanaka
| University of Hitotsubashi | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SONY GROUP CORPORATION | Electronic Technology |
| SHISEIDO COMPANY, LIMITED | Consumer Non-Durables |
| ASTELLAS PHARMA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Health Technology |
